Floatz logo

1.0% ip-001 for

Colon Cancer

Immunophotonics, Inc.Phase 1/2Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
65/ 100

Competitive context

157 Active assets in the Colon Cancer cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Akeso
Phase 4A
Irinotecan
Fudan University
Phase 3BBB
Floxuridine
City of Hope Medical Center
Phase 2BBB
FLUOROURACILUM
Akeso
Phase 4BB
Eloxatin
Sun Yat-sen University
Phase 3BB

View all 50 →

Same molecule, other indications

1.0% ip-001 for is also rated in:

Colon Cancer Liver MetastasesDormant
B
Indicative ·
57 / 100
View asset →
rectal cancerDormant
B
Indicative ·
57 / 100
View asset →
metastasis from malignant tumor of colonDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →